Cargando…
Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia
BACKGROUND: Vascular Dementia (VaD) refers to dementia caused by cerebrovascular disease and/or reduced blood flow to the brain and is the second most common form of dementia after Alzheimer’s disease. We previously found that in middle-aged rats subjected to a multiple microinfarction (MMI) model o...
Autores principales: | Gao, Huanjia, Findeis, Elizabeth L., Culmone, Lauren, Powell, Brianna, Landschoot-Ward, Julie, Zacharek, Alex, Wu, Trueman, Lu, Mei, Chopp, Michael, Venkat, Poornima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248134/ https://www.ncbi.nlm.nih.gov/pubmed/37304071 http://dx.doi.org/10.3389/fnagi.2023.1180913 |
Ejemplares similares
-
Treatment With an Angiopoietin-1 Mimetic Peptide Improves Cognitive Outcome in Rats With Vascular Dementia
por: Culmone, Lauren, et al.
Publicado: (2022) -
Treatment with an Angiopoietin‐1 mimetic peptide promotes neurological recovery after stroke in diabetic rats
por: Venkat, Poornima, et al.
Publicado: (2020) -
HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia
por: Venkat, Poornima, et al.
Publicado: (2020) -
Angiopoietin-1 Mimetic Peptide Promotes Neuroprotection after Stroke in Type 1 Diabetic Rats
por: Venkat, Poornima, et al.
Publicado: (2018) -
Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice
por: Venkat, Poornima, et al.
Publicado: (2023)